Empowering Physicians to
Preempt Cancer

An advanced diagnostic platform that leverages artificial intelligence (AI) enabled tissue analysis and 3D imaging to reliably detect precancerous cells.


WATS3D is included as an adjunct to routine biopsies for screening and surveillance of Barrett's esophagus in the published Guidelines of the American Society for Gastrointestinal Endoscopy (ASGE)


male doctor looking at tablet

Our Technology

AI-Enabled Tissue Analysis

CDx provides an integrated solution of enhanced tissue sampling and an AI-assisted diagnostic platform.

The powerful neural network finds a needle in a haystack. Advanced 3D imaging and analysis provide a unique view of the tissue. And genetic testing helps confirm the early diagnosis.

All this provides patients and their physicians with reliable diagnostic testing based on the most advanced science available.


See how CDx technology is helping physicians preempt cancer.

Learn More

support icon

Let us help you with questions about our products and services.  

Request Support

handshake icon
Patient Resources

Browse our library of information related to esophageal cancer prevention.

Learn More

physician finder icon
Physician Finder

Find doctors near you who use WATS3D.

Locate a Provider